Search by Drug Name or NDC

    NDC 62135-0669-90 Quinapril and Hydrochlorothiazide 25; 20 mg/1; mg/1 Details

    Quinapril and Hydrochlorothiazide 25; 20 mg/1; mg/1

    Quinapril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE.

    Product Information

    NDC 62135-0669
    Product ID 62135-669_0c3f4504-d57e-aa79-e063-6294a90ad5b8
    Associated GPIs
    GCN Sequence Number 041016
    GCN Sequence Number Description quinapril/hydrochlorothiazide TABLET 20 MG-25MG ORAL
    HIC3 A4J
    HIC3 Description ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC
    GCN 94490
    HICL Sequence Number 007826
    HICL Sequence Number Description QUINAPRIL HCL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Quinapril and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Quinapril and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25; 20
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
    Labeler Name Chartwell RX, LLC
    Pharmaceutical Class Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076374
    Listing Certified Through 2024-12-31

    Package

    NDC 62135-0669-90 (62135066990)

    NDC Package Code 62135-669-90
    Billing NDC 62135066990
    Package 90 TABLET in 1 BOTTLE (62135-669-90)
    Marketing Start Date 2023-12-05
    NDC Exclude Flag N
    Pricing Information N/A